TrademarkDir
PHARMASAVE
DEAD

Serial Number

85107442

Owner

PHARMASAVE DRUGS LTD.

Attorney

Lisa M. Melanson

First Use Date

Apr 30, 2014

Filing Date

Aug 13, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PHARMASAVE Trademark

Serial Number: 85107442 • Registration: 4552013

PHARMASAVE is a trademark filed by PHARMASAVE DRUGS LTD. on August 13, 2010. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

PHARMASAVE DRUGS LTD. (11 trademarks)

LANGLEY, BRITISH COLUMBIA V3A 4N4 , CA

Entity Type: 03

PHARMASAVE DRUGS (NATIONAL) LTD. (4 trademarks)

8411 - 200TH STREET
LANGLEY, BRITISH COLUMBIA V2Y0E7 , CA

Entity Type: 03

Trademark Details

Filing Date

August 13, 2010

Registration Date

June 17, 2014

First Use Anywhere

April 30, 2014

First Use in Commerce

April 30, 2014

Published for Opposition

March 8, 2011

Cancellation Date

January 22, 2021

Goods & Services

Retail drug store services; retail store services featuring medical preparations for external and internal use

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 22, 2021 C8..
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Sep 18, 2019 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 17, 2019 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2019 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 17, 2019 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2018 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 21, 2018 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 14, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
May 13, 2014 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 12, 2014 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 12, 2014 SUPC
USE AMENDMENT FILED
May 5, 2014 IUAF
TEAS STATEMENT OF USE RECEIVED
May 5, 2014 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2013 EXRA
SOU EXTENSION 5 GRANTED
Sep 12, 2013 EX5G
SOU EXTENSION 5 FILED
Sep 10, 2013 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 10, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2013 EXRA
SOU EXTENSION 4 GRANTED
Mar 13, 2013 EX4G
SOU EXTENSION 4 FILED
Mar 7, 2013 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 7, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2012 EXRA
SOU EXTENSION 3 GRANTED
Sep 6, 2012 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 6, 2012 AITU
SOU EXTENSION 3 FILED
Sep 4, 2012 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 4, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2012 EXRA
SOU EXTENSION 2 GRANTED
Mar 14, 2012 EX2G
SOU EXTENSION 2 FILED
Mar 14, 2012 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 14, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 13, 2011 EXRA
SOU EXTENSION 1 GRANTED
Oct 11, 2011 EX1G
SOU EXTENSION 1 FILED
Oct 11, 2011 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 11, 2011 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 3, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2011 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 1, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2011 CRFA
ASSIGNED TO LIE
Jan 11, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 16, 2010 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Dec 3, 2010 GPRN
PRIORITY ACTION E-MAILED
Dec 3, 2010 GPRA
PRIORITY ACTION WRITTEN
Dec 3, 2010 CPRA
ASSIGNED TO EXAMINER
Nov 30, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
Aug 20, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2010 NWOS
NEW APPLICATION ENTERED
Aug 17, 2010 NWAP

Related Trademarks

More from this Owner

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE

PHARMASAVE